Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Evaluation of the Incidence of Nausea and Vomiting in Patients With Colorectal Cancer Receiving Irinotecan-based Therapy

NCT00713128 is registered in ClinicalTrials.gov with Steward St. Elizabeth's Medical Center of Boston, Inc. as lead sponsor.

NCT NCT00713128
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00713128 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Evaluation of the Incidence of Nausea and Vomiting in Patients With Colorectal Cancer Receiving Irinotecan-based Therapy
Lead sponsor
Steward St. Elizabeth's Medical Center of Boston, Inc.
Phase
Observational
Overall status
Completed
Start date
April 30, 2008
Completion date
December 31, 2009
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer